HOME
AGENDA
SPEAKERS
REGISTRATION
LOCATION
CONTACTS
SPONSORS
INTERESTED IN SPEAKING?






Agenda

 

Plenary Session

09:00 - 09:30 Registration
   
09:30 - 09:40 Welcome
   
09:40 - 10:20 Evidence-based protocol feasibility and site selection – a new approach to the old problem of delayed patient accrual
read abstract >>
Grahaem Brown, Managing Partner, Competitive Drug Development Intl
   
10:20 - 11:00 The Real Strategic Impact of the EDC Revolution
read abstract >>
Spenser Groves, DM System Architecture Implementation Lead, Ipsen Biopharm Limited
   
11:00 - 11:30 Coffee Break
   
11:30 - 12:10 New Gateway communication between Clinical Research and Drug Safety. How to improve SUSAR reporting to Competent Authorities
read abstract >>

Juergen Schulberger, Product Manager for Extedos Pharmacovigilance product, Extedo
   
12:10 - 12:50 Adaptive Design: a bridge to personalized medicine
read abstract >>
Emmanuel Pham, VP Biometrics, Ipsen
   
12:50 - 13:50 Networking Lunch and Exhibitors Area
   
13:50 - 14:30 Lessons Learnt from ePRO a Reality Check
read abstract >>
Paul Terrill, Statistician, Cros NT
   
14:30 - 15:30

ROUND TABLE:


How Pharma Companies Define their Operating Strategies and to what Degree Information Technologies Influence these Strategies?
Emmanuel Pham, VP Biometrics, Ipsen
Joshua Pines, Director EMEA Marketing, Medidata Solutions Worldwide
Stefano Piccoli, Director of IT Quality Consultancy Services, Arithmos
Grahaem Brown, Managing Partner, Competitive Drug Development Intl
 

15:30 - 15:35 Discussion/conclusion of Plenary section
   
15:35 - 16:05 Coffee Break



New Technology Overview
 

16:05 - 16:25 Customizable EDC Solution for Late Phase Studies
read abstract >>
Gianluigi Albertini, Business Development Manager, Arithmos
   
16:25 - 16:45 Using Technology to Optimize Trial Design and Execution
read abstract >>
Andrew Gebbie, Business Consultant, Medidata Solutions Worldwide
   
16:45 - 16:50

Discussion/conclusion

 


 

Sponsored by


 

 

 

In collaboration with:

Media Partner: